Award
National Cancer Institute 5R01CA257009-05
Tunable Temporal Drug Release for Optimized Synergistic Combination Therapy of Glioblastoma
Recipient
UNIV OF NORTH CAROLINA CHAPEL HILL
Award Amount
$349,391.00
Ceiling
$349,391.00
Awarded
July 28, 2025
Identifier
5R01CA257009-05
NIH grant awarded for research on glioblastoma treatment focusing on controlled drug release to enhance chemotherapy effectiveness.
Description
This is a NIH grant project for research on glioblastoma treatment involving drug delivery systems, nanotechnology, and cancer therapy. The project aims to develop a controlled-release scaffold for chemotherapy drugs to improve patient outcomes.